Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

A room with a view: the health information master switch

In his latest blog, Alex Butler questions the very fundamentals of the democratic social web and asks whether pharma needs to look more closely at how access to online information is controlled. This week has been a very challenging one for me, one that has forced me to consider the very core beliefs I hold regarding the democratisation of information…

Articles

A room with a view: the six challenges of digital (part 1)

According to Alex Butler there are six key challenges that need addressing if an effective digital presence is to be established. In this first of his two-part article he addresses the first three. The first three posts dealt first with regulation and social media, then with how to measure social media effectively-viewing community engagement as…

Articles

A room with a view: patient centricity

‘Putting patients at the heart of the business’ is key to pharma but a meaningless phrase unless it’s applications is understood as Alex Butler explains. If we want to put patients first, tactics before strategy is the noise of defeat. There is little doubt that one of the hot topics of 2011 …

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.